Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000505261 | SCV001395610 | pathogenic | Cortical dysplasia-focal epilepsy syndrome | 2019-05-01 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg1016*) in the CNTNAP2 gene. It is expected to result in an absent or disrupted protein product. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the ExAC database. This variant has been observed in individual(s) with clinical features of Pitt-Hopkins-like syndrome (PMID: 27439707). In at least one individual the data is consistent with the variant being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 438342). Loss-of-function variants in CNTNAP2 are known to be pathogenic (PMID: 19896112, 21827697, 25045150, 26843181, 27439707). For these reasons, this variant has been classified as Pathogenic. |
Diagnostic Laboratory, |
RCV001260690 | SCV001437782 | uncertain significance | Intellectual disability | 2020-09-10 | criteria provided, single submitter | clinical testing | |
OMIM | RCV000505261 | SCV000599440 | pathogenic | Cortical dysplasia-focal epilepsy syndrome | 2017-09-07 | no assertion criteria provided | literature only |